Comparative Analysis of the Immune Profiles of Women and Men With Hepatocellular Carcinoma
Cancer Medicine · 2026
DOI: 10.1002/cam4.72297 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cancer Medicine, 2026. Verfasst von Zuzana Macek Jilkova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Grenoble Alpes, Grenoble, France. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ligue Contre le Cancer, Association Française pour l'Étude du Foie.
Abstract (Originalsprache)
Introduction
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and a major global health concern, with a higher incidence in men than in women. In the era of immunotherapy, understanding sex‐based immunological differences is crucial. Methods/Patients This study investigated sex‐specific differences in anti‐tumor immunity in HCC through immune profiling of liver biopsies and blood samples. A prospective cohort of 101 patients was analyzed by multiparametric flow cytometry to assess lymphocyte populations and immune checkpoint molecule expression on tumoral and nontumoral biopsies and blood samples. Then, a retrospective cohort of 56 patients was analyzed for circulating immune markers and functional assessment.
Results
Our findings indicate that while overall intrahepatic immune composition was similar between sexes, female patients exhibited higher intra‐tumoral PD‐1 high+ CD8 + T cell frequency compared to men (13.3% ± 2.6% vs. 6.5% ± 0.7%, p = 0.0127), suggesting greater T cell exhaustion. Additionally, NK cells expressing CTLA‐4 and ICOS were more frequent in females. Circulating immune profiles also differed, with female patients showing increased CTLA‐4 + CD4 + and CD8 + T cells ( p = 0.0005 and p = 0.0164) and reduced IFNγ expression, mainly in central memory CD8 + T cells.
Conclusions
These findings highlight the importance of considering sex‐related differences in the context of immunotherapy for HCC and underline the need for further investigation in larger cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Univ. Grenoble Alpes, Grenoble, France.
- Institute for Advanced Biosciences, Research Center UGA/Inserm U 1209/CNRS 5309, Grenoble, France.
- Hepato-Gastroenterology and Digestive Oncology Department, CHU Grenoble Alpes, Grenoble, France.
- Department of Radiology, CHU Grenoble Alpes, Grenoble, France.
ORCID-Profile: Zuzana Macek Jilkova, Christian Sengel, Yann Teyssier, Charlotte Costentin, Thomas Decaens
Förderung
- Ligue Contre le Cancer
- Association Française pour l'Étude du Foie
Zitieren
APA
Macek Jilkova, Z., Ghelfi, J., Dumolard, L., Sinniger, V., Mehdi, N. E. H., Sengel, C., Teyssier, Y., Costentin, C., & Decaens, T. (2026). Comparative Analysis of the Immune Profiles of Women and Men With Hepatocellular Carcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.72297
Vancouver
Macek Jilkova Z, Ghelfi J, Dumolard L, Sinniger V, Mehdi NEH, Sengel C, et al. Comparative Analysis of the Immune Profiles of Women and Men With Hepatocellular Carcinoma. Cancer Medicine. 2026. doi:10.1002/cam4.72297
BibTeX
@article{MacekJilkova2026,
author = {Macek Jilkova, Zuzana and Ghelfi, Julien and Dumolard, Lucile and Sinniger, Valerie and Mehdi, Nour El Houda and Sengel, Christian and Teyssier, Yann and Costentin, Charlotte and Decaens, Thomas},
title = {Comparative Analysis of the Immune Profiles of Women and Men With Hepatocellular Carcinoma},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.72297}
}
EUVIMED